Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,718.45
+126.49(+0.26%)

Best savings accounts that offer above inflation rates

How to earn the most interest on your savings

OrbusNeich Medical Group Holdings Limited (Q8T.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

0.5100

+0.0180

(+3.66%)

At close: 11:41AM CEST

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	445.24M
Enterprise value	214.89M
Trailing P/E	10.16
Forward P/E	13.72
PEG ratio (5-yr expected)	0.86
Price/sales (ttm)	2.98
Price/book (mrq)	1.24
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	-67.68%
S&P500 52-week change ³	26.27%
52-week high ³	1.5880
52-week low ³	0.3260
50-day moving average ³	0.4056
200-day moving average ³	0.7284

Share statistics

Avg vol (3-month) ³	30
Avg vol (10-day) ³	12
Shares outstanding ⁵	827.97M
Implied shares outstanding ⁶	873.02M
Float ⁸	235.91M
% held by insiders ¹	63.03%
% held by institutions ¹	12.34%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.01
Forward annual dividend yield ⁴	2.31%
Trailing annual dividend rate ³	0.01
Trailing annual dividend yield ³	2.64%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	11 Jun 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	29.29%
Operating margin (ttm)	21.21%

Management effectiveness

Return on assets (ttm)	6.46%
Return on equity (ttm)	13.03%

Income statement

Revenue (ttm)	153.86M
Revenue per share (ttm)	0.19
Quarterly revenue growth (yoy)	6.60%
Gross profit (ttm)	N/A
EBITDA	41.3M
Net income avi to common (ttm)	45.07M
Diluted EPS (ttm)	0.0500
Quarterly earnings growth (yoy)	90.30%

Balance sheet

Total cash (mrq)	256.21M
Total cash per share (mrq)	0.31
Total debt (mrq)	7.46M
Total debt/equity (mrq)	2.02%
Current ratio (mrq)	9.77
Book value per share (mrq)	0.44

Cash flow statement

Operating cash flow (ttm)	23.03M
Levered free cash flow (ttm)	5.32M